Interplay of synaptic changes, neuroinflammation and beta-amyloid in cognitively normal subjects with varying risk of late-onset Alzheimer's disease (ASIC-E4)

Bidragets beskrivning

Early brain changes in unsymptomatic phase of Alzheimer's disease (AD) need to be characterized better, to enable successful disease modifying treatments in the future. The presence of epsilon 4-allele of Apolipoprotein E (APOE4) gene is the most important genetic risk factor for the more common late-onset AD. This study uses molecular neuroimaging and fluid-based biomarker methods to uncover the interplay of synaptic loss, neuroinflammation, amyloid deposition and structural brain changes in cognitively normal elderly volunteers with high, medium or low risk for AD due to different APOE genotype. Results provide much needed information about the presence and relationship of early biomarkers in preclinical AD. In addition, the study validates methods that could be utilized in early detection of AD pathologies, screening of study subjects and investigating effects of novel disease modifying compounds targeted against synaptic restoration and neuroinflammation in the future.
Visa mer

Startår

2021

Slutår

2024

Beviljade finansiering

Anniina Snellman Orcid -palvelun logo
228 610 €

Finansiär

Finlands Akademi

Typ av finansiering

Forskardoktorer

Övriga uppgifter

Finansieringsbeslutets nummer

341059

Vetenskapsområden

Neurovetenskaper

Forskningsområden

Neurotiede

Identifierade teman

brain, neuroscience